Clifford Swan Investment Counsel’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Sell
2,801
-25
-0.9% -$2.02K 0.01% 323
2026
Q1
$245K Buy
2,826
+18
+0.6% +$1.72K 0.01% 300
2025
Q4
$270K Hold
2,808
0.01% 281
2025
Q3
$267K Sell
2,808
-28
-1% -$2.57K 0.01% 285
2025
Q2
$247K Sell
2,836
-48
-2% -$4.07K 0.01% 288
2025
Q1
$259K Sell
2,884
-1,025
-26% -$91.7K 0.01% 280
2024
Q4
$312K Hold
3,909
0.01% 262
2024
Q3
$352K Sell
3,909
-278
-7% -$23.4K 0.01% 257
2024
Q2
$330K Hold
4,187
0.01% 255
2024
Q1
$365K Hold
4,187
0.01% 247
2023
Q4
$345K Sell
4,187
-2,201
-34% -$168K 0.01% 249
2023
Q3
$501K Sell
6,388
-430
-6% -$36K 0.02% 209
2023
Q2
$601K Sell
6,818
-959
-12% -$82.6K 0.02% 203
2023
Q1
$627K Sell
7,777
-119
-2% -$9.7K 0.03% 199
2022
Q4
$614K Sell
7,896
-466
-6% -$37.8K 0.03% 198
2022
Q3
$675K Sell
8,362
-1,165
-12% -$105K 0.03% 188
2022
Q2
$855K Sell
9,527
-1,672
-15% -$169K 0.04% 180
2022
Q1
$1.24M Hold
11,199
0.05% 164
2021
Q4
$1.16M Sell
11,199
-21
-0.2% -$2.43K 0.04% 176
2021
Q3
$1.35M Sell
11,220
-339
-3% -$43.9K 0.05% 168
2021
Q2
$1.48M Sell
11,559
-2,347
-17% -$295K 0.06% 152
2021
Q1
$1.64M Hold
13,906
0.07% 145
2020
Q4
$1.63M Buy
13,906
+25
+0.2% +$2.75K 0.07% 145
2020
Q3
$1.44M Sell
13,881
-300
-2% -$30.1K 0.07% 147
2020
Q2
$1.3M Sell
14,181
-200
-1% -$19.2K 0.07% 156
2020
Q1
$1.3M Sell
14,381
-2,050
-12% -$218K 0.08% 138
2019
Q4
$1.86M Hold
16,431
0.09% 135
2019
Q3
$1.78M Sell
16,431
-1,500
-8% -$157K 0.09% 135
2019
Q2
$1.75M Buy
17,931
+304
+2% +$27.8K 0.09% 139
2019
Q1
$1.6M Hold
17,627
0.09% 140
2018
Q4
$1.6M Sell
17,627
-16
-0.1% -$1.5K 0.1% 128
2018
Q3
$1.74M Sell
17,643
-100
-0.6% -$9.24K 0.09% 128
2018
Q2
$1.52M Buy
17,743
+16
+0.1% +$1.34K 0.08% 138
2018
Q1
$1.42M Hold
17,727
0.08% 140
2017
Q4
$1.43M Sell
17,727
-700
-4% -$56.1K 0.08% 142
2017
Q3
$1.43M Buy
18,427
+2,059
+13% +$171K 0.09% 134
2017
Q2
$1.45M Buy
16,368
+2,108
+15% +$178K 0.09% 135
2017
Q1
$1.15M Buy
14,260
+125
+0.9% +$9.76K 0.07% 139
2016
Q4
$1.01M Buy
14,135
+375
+3% +$29.5K 0.07% 145
2016
Q3
$1.19M Sell
13,760
-1,185
-8% -$103K 0.08% 138
2016
Q2
$1.3M Sell
14,945
-1,114
-7% -$90.1K 0.09% 129
2016
Q1
$1.2M Sell
16,059
-1,200
-7% -$90.4K 0.08% 138
2015
Q4
$1.33M Sell
17,259
-2,000
-10% -$151K 0.09% 136
2015
Q3
$1.29M Sell
19,259
-3,412
-15% -$251K 0.09% 131
2015
Q2
$1.68M Sell
22,671
-4,300
-16% -$329K 0.11% 122
2015
Q1
$2.1M Sell
26,971
-21,418
-44% -$1.62M 0.14% 110
2014
Q4
$3.49M Sell
48,389
-8,347
-15% -$580K 0.23% 91
2014
Q3
$3.52M Sell
56,736
-398
-0.7% -$25.3K 0.24% 87
2014
Q2
$3.64M Sell
57,134
-1,009
-2% -$61.3K 0.25% 88
2014
Q1
$3.58M Buy
58,143
+103
+0.2% +$6K 0.25% 88
2013
Q4
$3.33M Sell
58,040
-727
-1% -$41.2K 0.24% 88
2013
Q3
$3.13M Sell
58,767
-1,140
-2% -$61.3K 0.25% 87
2013
Q2
$3.08M Buy
+59,907
New +$2.96M 0.26% 84

Other funds holding MDT

Clifford Swan Investment Counsel's MDT Position: Q2 2026 in Review

Clifford Swan Investment Counsel reduced its Medtronic (MDT) stake by 0.88% in Q2 2026, selling an estimated $2.02K and leaving 2,801 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #323.

Clifford Swan Investment Counsel first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.64M in Q2 2014. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Clifford Swan Investment Counsel held 2,801 shares of Medtronic worth $219K as of Q2 2026.
  • Clifford Swan Investment Counsel sold 25 Medtronic shares in Q2 2026, an estimated $2.02K.
  • Medtronic made up 0.01% of Clifford Swan Investment Counsel's portfolio in Q2 2026, its #323 holding.
  • Clifford Swan Investment Counsel first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Clifford Swan Investment Counsel's Medtronic position peaked at $3.64M in Q2 2014.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Clifford Swan Investment Counsel's 13F filing for Q2 2026, filed 20 Aug 2026.